HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kwesi Teye Selected Research

Desmocollins

1/2021Autoantibodies to DSC3 in Pemphigus Exclusively Recognize Calcium-Dependent Epitope in Extracellular Domain 2.
8/2016Case of paraneoplastic pemphigus with immunoglobulin (Ig)G and IgA antibodies to various antigens.
4/2016Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3.
1/2016Anti-early endosome antigen 1 autoantibodies were detected in a pemphigus-like patient but not in the majority of pemphigus diseases.
3/2014IgA paraneoplastic pemphigus in angioimmunoblastic T-cell lymphoma with antibodies to desmocollin 1, type VII collagen and laminin 332.
10/2013Two cases of pemphigus vegetans with IgG anti-desmocollin 3 antibodies.
7/2013Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins.
5/2013IgA pemphigus with non-pustular erythematous lesions and IgA antibodies to desmocollins 1 and 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kwesi Teye Research Topics

Disease

16Pemphigus (Pemphigus Vulgaris)
07/2022 - 05/2013
8Skin Diseases (Skin Disease)
07/2022 - 05/2013
5Bullous Pemphigoid (Pemphigoid)
11/2019 - 04/2016
3Blister (Bulla)
04/2016 - 02/2013
2Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
07/2022 - 05/2013
2Atopic Dermatitis (Atopic Eczema)
02/2021 - 05/2017
2Carcinogenesis
01/2016 - 05/2005
2Starvation
01/2016 - 05/2010
2Benign Familial Pemphigus (Hailey Hailey Disease)
07/2014 - 02/2013
2Erythema
01/2014 - 05/2013
2Neoplasms (Cancer)
11/2004 - 01/2004
1Multiple Myeloma
07/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2022
1Disease Progression
07/2022
1Monoclonal Gammopathy of Undetermined Significance
07/2022
1Pathologic Complete Response
12/2019
1Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
05/2017
1Skin Neoplasms (Skin Cancer)
01/2017
1Bronchiolitis Obliterans
02/2016
1Linear IgA Bullous Dermatosis
09/2015
1Inflammation (Inflammations)
08/2015
1T-Cell Lymphoma (Lymphoma, T Cell)
03/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2013
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
02/2013
1Epidermolytic Palmoplantar Keratoderma
02/2013
1Darier Disease (Darier's Disease)
02/2013
1Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
02/2013
1Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome)
02/2013
1Hyperkeratosis of the palms and soles and esophageal papillomas
02/2013
1Naxos disease
02/2013
1Lymphoma (Lymphomas)
10/2007
1Colonic Neoplasms (Colon Cancer)
10/2007
1Esophageal Squamous Cell Carcinoma
10/2007
1Body Weight (Weight, Body)
12/2002
1Leukemia
09/2002

Drug/Important Bio-Agent (IBA)

13AntibodiesIBA
01/2021 - 05/2013
9AutoantibodiesIBA
07/2022 - 07/2013
9Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2002
8DesmocollinsIBA
01/2021 - 05/2013
7Immunoglobulin A (IgA)IBA
07/2022 - 05/2013
7Immunoglobulin G (IgG)IBA
01/2021 - 07/2013
5AntigensIBA
01/2017 - 05/2013
5AutoantigensIBA
08/2016 - 10/2013
4DesmogleinsIBA
01/2021 - 10/2013
4EnzymesIBA
01/2018 - 05/2010
3ImmunosorbentsIBA
01/2018 - 08/2016
2Filaggrin ProteinsIBA
02/2021 - 05/2017
2EpitopesIBA
01/2021 - 04/2016
2CalciumIBA
01/2021 - 02/2013
2Monoclonal AntibodiesIBA
01/2017 - 10/2007
2Immunoglobulins (Immunoglobulin)IBA
08/2016 - 04/2016
2Desmoglein 3IBA
04/2016 - 03/2014
2Messenger RNA (mRNA)IBA
07/2014 - 09/2002
2Desmoglein 1IBA
03/2014 - 01/2014
2Biomarkers (Surrogate Marker)IBA
11/2004 - 01/2004
1Edetic Acid (EDTA)FDA Link
01/2021
1Immunoglobulin M (IgM)IBA
01/2017
1envoplakinIBA
08/2016
1Recombinant ProteinsIBA
04/2016
1epiplakinIBA
02/2016
1Biological ProductsIBA
01/2016
1early endosome antigen 1IBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1IntegrinsIBA
09/2015
1Indicators and Reagents (Reagents)IBA
08/2015
1shikoninIBA
08/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2015
1Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
03/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2015
1Adenosine Triphosphatases (ATPase)IBA
07/2014
1KalininIBA
03/2014
1Collagen Type VIIIBA
03/2014
1Cadherins (E-Cadherin)IBA
07/2013
1Rituximab (Mabthera)FDA Link
07/2013
1Prednisolone (Predate)FDA LinkGeneric
05/2013
1PlakophilinsIBA
02/2013
1Keratins (Keratin)IBA
02/2013
1Histones (Histone)IBA
05/2010
1Succinic Acid (Succinate)IBA
05/2010
1Ribosomal DNA (rDNA)IBA
05/2010
1Ribosomal RNAIBA
05/2010
1CholesterolIBA
12/2002
1oxidized low density lipoproteinIBA
12/2002
1HDL CholesterolIBA
12/2002
1LDL CholesterolIBA
12/2002
1phorbolIBA
09/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2019